News

Filter

Current filters:

ReproductiveOncology

1 to 9 of 20 results

New chemo drug gentler on fertility, tougher on cancer

24-03-2013

A new gentler chemotherapy drug in the form of nanoparticles has been designed by Northwestern Medicine…

OncologyPharmaceuticalReproductiveResearch

In Japan, AstraZeneca to co-promote denosumab with Daiichi; Sosei debuts NorLevo

24-05-2011

Anglo-Swedish drug major AstraZeneca (LSE: AZN) today announced a co-promotion agreement in Japan with…

Asia-PacificAstraZenecaBiotechnologyDaiichi SankyodenosumabMarkets & MarketingNorLevoOncologyPharmaceuticalReproductiveSoseiXgeva

ProStrakan agrees refinancing and distribution deal with Paladin Labs

20-12-2010

Scotland-based specialty drugmaker ProStrakan Group (LSE: PSK) and Canada’s Paladin Labs say that…

FinancialLicensingNeurologicalOncologyPaladin LabsPharmaceuticalProStrakanReproductive

US FDA approves Bayer’s Beyaz, a combination contraceptive with folate, and Allergan’s Ozurdex

26-09-2010

The US Food and Drug Administration on Friday approved Beyaz tablets, an estrogen/progestin combined…

AllerganBayerBeyazNorth AmericaNovartisOncologyOzurdexPharmaceuticalRegulationReproductive

Bayer in deal with UK’s cancer group to evaluate peptide for gynecological and cancer applications

25-08-2010

Bayer Schering Pharma AG, part of Germany’s Bayer Group (BAY: DE), has signed an agreement with…

BayerCancer Research TechnologyLicensingOncologyPharmaceuticalReproductiveResearch

Novartis gets US FDA approval for new Tasigna indication; agency panel backs HRA Pharma's ulipristal

18-06-2010

Following a priority review, the US Food and Drug Administration yesterday approved a new indication…

HRA PharmaNorth AmericaNovartisOncologyPharmaceuticalRegulationReproductiveTasignaulipristal

1 to 9 of 20 results

COMPANY SPOTLIGHT

Menarini

Back to top